Your browser doesn't support javascript.
loading
Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety.
Elfadadny, Ahmed; Ragab, Rokaia F; Hamada, Rania; Al Jaouni, Soad K; Fu, Junjiang; Mousa, Shaker A; El-Far, Ali H.
Afiliación
  • Elfadadny A; Department of Animal Internal Medicine, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt; Cooperative Division of Veterinary Sciences, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan. Electronic address: ahmed.elfadadny@vetmed.
  • Ragab RF; Cooperative Division of Veterinary Sciences, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan; Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt. Electronic address: rokia.fathy@vetmed.dmu.edu.eg.
  • Hamada R; Department of Pathology, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt. Electronic address: rania.hamada@vetmed.dmu.edu.eg.
  • Al Jaouni SK; Department of Hematology/Pediatric Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Electronic address: saljaouni@kau.edu.sa.
  • Fu J; Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China. Electronic address: fujunjiang@swmu.edu.cn.
  • Mousa SA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA. Electronic address: shaker.mousa@acphs.edu.
  • El-Far AH; Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt. Electronic address: ali.elfar@damanhour.edu.eg.
Toxicol Appl Pharmacol ; 461: 116405, 2023 02 15.
Article en En | MEDLINE | ID: mdl-36716865

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / ADN-Topoisomerasas de Tipo II Límite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / ADN-Topoisomerasas de Tipo II Límite: Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos